Making c4+ products in bacteria
US-2015376658-A1 · Dec 31, 2015 · US
US9631210B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9631210-B2 |
| Application number | US-201214345147-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 13, 2012 |
| Priority date | Sep 14, 2011 |
| Publication date | Apr 25, 2017 |
| Grant date | Apr 25, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to methods and compositions for increasing production of 3-methyl-2-butenol in a de novo synthetic pathway in a genetically modified host cell using isopentenyl disphosphate (IPP) as a substrate.
Opening claim text (preview).
What is claimed is: 1. A genetically modified host cell transformed with a nucleic acid construct encoding a fusion protein comprising a phosphatase capable of catalyzing the dephosphorylation of dimethylallyl diphosphate (DMAPP) linked to an isopentyl pyrophosphate (IPP) isomerase capable of converting IPP to DMAPP, wherein the nucleic acid construct is operably linked to a promoter. 2. The genetically modified host cell of claim 1 , wherein the genetically modified host cell further comprises a nucleic acid encoding a reductase that is capable of converting 3-methyl-2-butenol to 3-methy-butanol. 3. The genetically modified host cell of claim 2 , wherein the reductase is encoded by a nucleic acid construct introduced into the cell. 4. The genetically modified host cell of claim 1 , wherein the IPP isomerase is a Type I isomerase. 5. The genetically modified host cell of claim 4 , wherein the IPP isomerase is encoded by the E. coli idi gene or the Saccharomyces cerevisiae idil gene. 6. The genetically modified host cell of claim 1 , wherein the phosphatase is a member of the Nudix superfamily. 7. The genetically modified host cell of claim 6 , wherein the phosphatase is encoded by the E. coli nudB gene. 8. The genetically modified host cell of claim 1 , wherein the host cell is a prokaryotic cell selected from Escherichia, Enterobacter, Azotobacter, Erwinia, Bacillus, Pseudomonas, Klebsielia, Proteus, Salmonella, Serratia, Shigella, Rhizobia , Vitreoscilla, Synechococcus, Synechocystis , or Paracoccus taxonomical classes. 9. The genetically modified host cell of claim 8 , wherein the prokaryotic cell is an Escherichia coli cell. 10. The genetically modified host cell of claim 1 , wherein the host cell is a fungal cell. 11. The genetically modified host cell of claim 10 , wherein the fungal cell is a yeast cell. 12. The genetically modified host cell of claim 11 , wherein the yeast cell is a Saccharomyces sp. cell. 13. The genetically modified host cell of claim 1 , wherein the host cell is an algal, insect or mammalian cell line. 14. The genetically modified host cell of claim 1 , wherein the IPP isomerase is encoded by the E. coli idi gene or the Saccharomyces cerevisiae idil gene; and the phosphatase is encoded by the E. coli nudB gene. 15. The genetically modified host cell of claim 14 , wherein the host cell is a prokaryotic cell. 16. The genetically modified host cell of claim 15 , wherein the host cell is a prokaryotic cell selected from Escherichia, Enterobacter, Azotobacter, Erwinia, Bacillus, Pseudomonas, Klebsielia, Proteus, Salmonella, Serratia, Shigella, Rhizobia, Vitreoscilla, Synechococcus, Synechocystis , or Paracoccus taxonomical classes. 17. The genetically modified host cell of claim 15 , wherein the prokaryotic cell is an Escherichia coli cell. 18. A method of enhancing production of a 3-methyl-2-butenol, the method comprising culturing a genetically modified host cell transformed with a nucleic acid construct encoding a fusion protein comprising a phosphatase capable of catalyzing the dephosphorylation of DMAPP linked to IPP isomerase capable of converting IPP to DMAPP, wherein the nucleic acid construct is operably linked to a promoter, under conditions such that the culturing results in the expression of the fusion protein and production of 3-methyl-2-butenol. 19. The method of claim 18 , further comprising recovering 3-methyl-2-butenol produced by the genetically modified host cell. 20. The method of claim 18 , wherein the genetically modified host cell further comprises a nucleic acid encoding a reductase such that expression of the reductase converts 3-methyl-2-butenol to 3-methyl butanol. 21. The method of claim 20 , wherein the reductase is encoded by a nucleic acid construct introduced into the genetically modified host cell. 22. The method of claim 20 , further comprising recovering 3-methyl-2-butenol or 3-methyl butanol produced by the genetically modified host cell. 23. The method of claim 18 , wherein the IPP isomerase is a Type I isomerase. 24. The method of claim 23 , wherein the IPP isomerase is encoded by the E. coli idi gene or the Saccharomyces cerevisiae idil gene. 25. The method of claim 18 , wherein the phosphatase is a member of the Nudix superfamily. 26. The method of claim 25 , wherein the phosphatase is encoded by the E. coli nudB gene. 27. The method of claim 18 , wherein the genetically modified host cell is a prokaryotic cell selected from Escherichia, Enterobacter, Azotobacter, Erwinia, Bacillus, Pseudomonas, Klebsielia, Proteus, Salmonella, Serratia, Shigella, Rhizobia, Vitreoscilla, Synechococcus, Synechocystis , or Paracoccus taxonomical classes. 28. The method of claim 27 , wherein the prokaryotic cell is an Escherichia coli cell. 29. The method of claim 18 , wherein the genetically modified host cell is a fungal cell. 30. The method of claim 29 , wherein the fungal cell is a yeast cell. 31. The method of claim 30 , wherein the yeast cell is a Saccharomyces sp. cell. 32. The method of claim 18 , wherein the genetically modified host cell is an algal, insect or mammalian cell line. 33. The method of claim 18 , wherein the IPP isomerase is encoded by the E. coli idi gene or the Saccharomyces cerevisiae idil gene; and the phosphatase is encoded by the E. coli nudB gene. 34. The method of claim 33 , wherein the genetically modified host cell is a prokaryotic cell. 35. The method of claim 34 , wherein the prokaryotic cell is selected from Escherichia, Enterobacter, Azotobacter, Erwinia, Bacillus, Pseudomonas, Klebsielia, Proteus, Salmonella, Serratia, Shigella, Rhizobia , Vitreoscilla, Synechococcus, Synechocystis , or Paracoccus taxonomical classes. 36. The method of claim 34 , wherein the prokaryotic cell is an Escherichia coli cell.
Isomerases (5.) · CPC title
Butanols · CPC title
Biofuels, e.g. bio-diesel · CPC title
Isopentenyl-diphosphate DELTA-isomerase (5.3.3.2) · CPC title
DNA sequences coding for fusion proteins · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.